HomeTechnical SetupSUDEEPPHRM
39tech score
/ 100

Sudeep Pharma Limited (SUDEEPPHRM) — Technical Setup

₹1,155 +4.49%   Strong Uptrend Normal Volatility Bearish

As of 2026-09-18 close Sector: Pharma Pharmaceuticals

Summary

Sudeep Pharma Limited is in a strong uptrend on the daily chart. RSI(14) is 50.7, MACD is below its signal line, ADX reads 55 (trending). The stock trades 51.7% above its 200-day average and 16.2% below its 52-week high. Volume in the latest session was 0.8× its 20-day average. Over three months it has outperformed the Nifty 50 by 42.1 percentage points. Nearest support is ₹894.45 and resistance ₹1,169.30. Its technical score is 39/100 (bearish).

Trend (daily)
Bullish
Trend (weekly)
Bullish
Trend (monthly)
RSI (14)
50.73
MACD
Bearish
ADX (14)
55.26
Volume vs 20d avg
0.82×
Support
₹894.45 (−22.6%)
Resistance
₹1,169.30 (+1.2%)
RS vs Nifty (3M)
+42.10%
RS rating
93.00

🧮 How the 39/100 is built

Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.

Trend14/20
  • Close above 20-day EMA (-1.41)0/3
  • 20-day EMA above 50-day EMA3/3
  • 50-day EMA above 200-day EMA3/3
  • Close above 200-day SMA (51.71)3/3
  • SuperTrend (10,3) pointing up0/3
  • ADX ≥ 20 with +DI above −DI (trend has strength) (55.26)3/3
  • Weekly trend up (above a rising 30-week average)2/2
Momentum9/20
  • RSI(14) in the bullish zone (55-70 best) (50.73)4/6
  • MACD line above its signal line0/4
  • MACD line above zero (29.63)3/3
  • 12-day rate of change positive (-6.17)0/3
  • Stochastic %K above %D0/2
  • Outperforming the Nifty 50 over 3 months (42.10)2/2
Volume5/20
  • On-balance volume rising over 20 sessions0/5
  • Chaikin Money Flow (20) positive (-0.02)0/5
  • More volume on up days than down days (20 sessions) (1.11)5/5
  • Close above 20-day VWAP (-4.21)0/5
Volatility11/20
  • Daily range (ATR%) contained — ≤2.5% scores full (5.46)2/6
  • Price in the upper half of its Bollinger Bands (0.36)2/5
  • Shallow drawdown from the 52-week high (-16.18)3/5
  • Volatility contracting (20-day volatility below its 6-month median) (48.80)4/4
Support / Resistance0/20
  • Room to the next resistance (≥8% scores full) (1.24)0/5
  • Support close below (a tight, definable stop) (22.56)0/5
  • Broke above a 20-day high in the last 5 sessions0/5
  • Within 5% of the 52-week high (-16.18)0/5

🧭 Regime: Strong Uptrend

Normal Volatility — Bollinger width is in the 74th percentile of the last six months.

Suits: Trend-following. Pullbacks to the 20-day EMA and breakouts tend to be bought in strong trends; mean-reversion shorts fight the tape.

Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.

Opens the AI Backtester with the Momentum Breakout rules for SUDEEPPHRM — close at a 20-day high on 1.5× average volume, rsi above 55.

🕰️ Multi-timeframe

TimeframeTrendRSI (14)MACD hist.
Monthly
Weekly▲ Bullish61.1836.06
Daily▲ Bullish50.73-26.79

Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: Bullish, weekly ADX 44.66.

📶 Volume & VWAP

Relative volume
0.82×
5d / 20d volume
1.51×
Volume ROC (10d)
+32.52%
Up/down volume
1.11×
OBV (20d)
Falling / flat
Chaikin MF (20)
-0.02
VWAP 20d
₹1,206 (-4.21%)
VWAP 50d
₹1,050 (+10.03%)
Anchored VWAP · 52W low
₹865.71 (+33.42%)
Anchored VWAP · 52W high
₹1,203 (-4.01%)
Anchored VWAP · YTD
₹834.52 (+38.40%)
Avg turnover (20d)
₹32 Cr

VWAPs are computed from daily bars (typical price × volume), not intraday ticks.

💪 Relative strength

vs Nifty 1M
+2.92%
vs Nifty 3M
+42.10%
vs Nifty 6M
+91.60%
vs Nifty 1Y
RS rating
93.00
Mansfield RS
vs Pharma index 3M
+31.10%
vs sector peers 3M
+29.41%

SUDEEPPHRM ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.

🧱 Support & resistance

Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.

LevelPriceDistanceTouches
Resistance₹1,378.00+19.3%1
Resistance₹1,169.30+1.2%2
Close₹1,155
Support₹894.45−22.6%3
Support₹803.65−30.4%5
Support₹644.90−44.2%15

52-week range: ₹524.05 – ₹1,378 (-16.18% from the high).

🌀 Fibonacci

Measuring the up-swing from ₹585.20 (2026-03-30) to ₹1,378.00 (2026-09-07). Price has retraced 28.1% of it.

RatioPriceDistance
23.6% retracement₹1,190.90+3.1% nearest
38.2% retracement₹1,075.15-6.9%
50.0% retracement₹981.60-15.0%
61.8% retracement₹888.05-23.1%S/R confluence
78.6% retracement₹754.86-34.6%
127.2% extension₹1,593.64+38.0%
161.8% extension₹1,867.95+61.7%
200.0% extension₹2,170.80+88.0%

🕯️ Candlesticks (last 5 sessions)

Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.

↗️ Divergences

No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.

🏭 Pharma peers by technical score
Stock Close Chg Score Trend regimeRS rating (1-99)
AUROPHARMAAurobindo Pharma Limited ₹1,734 +2.60% 94 Uptrend 84.00
AAREYDRUGSAarey Drugs & Pharmaceuticals Limited ₹102.13 +0.40% 85 Strong Uptrend 86.00
ACUTAASAcutaas Chemicals Limited ₹3,440 +3.78% 85 Uptrend 93.00
KOPRANKopran Limited ₹277.60 +3.35% 85 Strong Uptrend 96.00
BAFNAPHBafna Pharmaceuticals Limited ₹317.20 +1.99% 84 Strong Uptrend 98.00
KILITCHKilitch Drugs (India) Limited ₹191.45 +1.47% 84 Uptrend 63.00
CAPLIPOINTCaplin Point Laboratories Limited ₹2,749 +5.85% 83 Uptrend 83.00
GLANDGland Pharma Limited ₹2,962 +1.86% 83 Strong Uptrend 91.00
JUBLPHARMAJubilant Pharmova Limited ₹1,065 +5.27% 80 Strong Uptrend 64.00
STARStrides Pharma Science Limited ₹1,220 +1.63% 80 Strong Uptrend 81.00
🔗 More on SUDEEPPHRM

⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.

⚠️ AI Disclaimer: This website is entirely managed by AI Agents and may contain errors or inaccuracies. Always verify information from multiple sources before making any financial or investment decisions.